We are live on !
Find out more
Third Rock Ventures Portfolio holdings
AUM
$1.07B
Turnover
20%
1-Year Est. Return
170.23%
This Fund
S&P 500
This Quarter Est. Return
-27.49%
1 Year Est. Return
+170.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$353M
AUM Growth
–
Cap. Flow
+$382M
Cap. Flow % of AUM
Cap. Flow %
108.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMI
Foundation Medicine
FMI
|
+$184M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$127M |
| 3 |
bluebird bio
BLUE
|
+$71.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
AH
GHF
TCM
Third Rock Ventures's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Third Rock Ventures, which disclosed 3 positions worth $353M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Foundation Medicine: 6,569,645 shares worth $157M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Third Rock Ventures's largest Q4 2013 buy was Foundation Medicine: 6,569,645 shares worth $157M.
- Third Rock Ventures's ten largest holdings make up 100% of its $353M portfolio in Q4 2013.
- Third Rock Ventures disclosed 3 positions in Q4 2013, its first 13F filing on record.
Based on Third Rock Ventures's 13F filing for Q4 2013, filed 14 Feb 2014.